Raymed Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in U T, Chandigarh, India, established in 1995.
1995 U T, Chandigarh, India Active
Last Updated:
Access Report
About Raymed Pharmaceuticals Limited

Raymed Pharmaceuticals Limited, a active public limited company, was established on 10 January 1995 in U T, Chandigarh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231CH1995PLC015598. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.71 M.

It upholds a compliant status. Employing 8 professional, Its leadership includes Tarsem Kumar Ruby (Director), Veeta Sharma (Director), Shivansh Sharma (Director). Past directors included Shivansh Sharma, Sanjay Jhamb, Sat Parkash Mittal. It holds ₹4.46 Cr open charges and ₹8.66 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 859Manimajra Chandigarh, U T, Chandigarh, 160101.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231CH1995PLC015598

  • Registration Number

    015598

  • Incorporation Date

    10 January 1995

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹1.71 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 1.71 M
  • Company Age 31 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 4.46 Cr
  • Satisfied Charges ₹ 8.66 M
  • Revenue Growth **** 23.29%
  • Profit Growth **** 91.08%
  • Ebitda **** 38.35%
  • Net Worth 34.24%
  • Total Assets **** 42.20%
Company report

Raymed Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Raymed Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Raymed Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Tarsem Kumar Ruby Director 10 Jan 1995 Current
Veeta Sharma Director 30 Mar 1997 Current
Shivansh Sharma Director 17 Apr 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 25 Sep 2015 Past
Pramod Abcsdd Director 06 Dec 2022 Past
Pramod Abcsdd Director 31 Aug 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Raymed Pharmaceuticals.

Raymed Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.29% increase. The company also saw a substantial improvement in profitability, with a 91.08% increase in profit. The company's net worth Soared by an impressive increase of 34.24%.

Raymed Pharmaceuticals revenue growth over time
Raymed Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 23.29%
*******
*******
*******
*******
Revenue from Operations
*******
 23.06%
*******
*******
*******
*******
Total Assets
*******
 42.20%
*******
*******
*******
*******
Profit or Loss
*******
 91.08%
*******
*******
*******
*******
Net Worth
*******
 34.24%
*******
*******
*******
*******
EBITDA
*******
 38.35%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Raymed Pharmaceuticals?

In 2023, Raymed Pharmaceuticals had a promoter holding of 40.67% and a public holding of 59.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹44,600,000.00

Satisfied Charges

₹8,660,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 3.80 Cr
  • Axis Bank Limited : 0.60 Cr
  • Union Bank Of India : 0.06 Cr
Latest Charge Details
Date Lender Amount Status
30 Aug 2023 Axis Bank Limited ₹6.00 M Open
19 Jun 2023 Hdfc Bank Limited ₹8.00 M Open
26 Dec 2022 Hdfc Bank Limited ₹3.00 Cr Open
08 Nov 2004 Union Bank Of India ₹0.60 M Open
23 Dec 2004 Union Bank Of India ₹0.16 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Raymed Pharmaceuticals?

Raymed Pharmaceuticals has a workforce of 8 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Raymed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raymed Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Raymed Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Raymed Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Raymed Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 3.00 Cr registered on 26 Dec 2022 with Charge ID 100669059 was modified on 12 Mar 2024. was completed.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 0.60 Cr with Charge ID 100781239 was registered on 30 Aug 2023. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.80 Cr with Charge ID 100770796 was registered on 19 Jun 2023. was documented.

  • Charges

    The activity A charge registered on 23 Dec 2004 via Charge ID 90170068 with Union Bank Of India was fully satisfied on 05 Apr 2023. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Raymed Pharmaceuticals Limited?

The CIN of Raymed Pharmaceuticals Limited is U24231CH1995PLC015598.

Where is Raymed Pharmaceuticals Limited headquartered?

Raymed Pharmaceuticals Limited is headquartered at 859Manimajra Chandigarh, U T, Chandigarh, 160101.

When was Raymed Pharmaceuticals Limited incorporated?

Raymed Pharmaceuticals Limited was incorporated on 10 January 1995.

Who are the current directors of Raymed Pharmaceuticals Limited?

The current directors of Raymed Pharmaceuticals Limited are

What is the primary industry of Raymed Pharmaceuticals Limited?

The primary industry of Raymed Pharmaceuticals Limited is Manufacturing.

Is Raymed Pharmaceuticals Limited a listed company?

Raymed Pharmaceuticals Limited is unlisted.

What is the capital structure of Raymed Pharmaceuticals Limited?

The authorized capital of Raymed Pharmaceuticals Limited is ₹1.00 Cr, and the paid-up capital is ₹1.71 M.

What is the compliance status of Raymed Pharmaceuticals Limited?

The compliance status of Raymed Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available